DaVita Inc

詳細情報 DaVita Inc 企業名

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

企業情報

企業コードDVA

会社名DaVita Inc

上場日Oct 31, 1995

設立日1994

最高経営責任者「CEO」Mr. Javier J. Rodriguez

従業員数76000

証券種類Ordinary Share

決算期末Oct 31

本社所在地2000 16th St

都市DENVER

証券取引所NYSE Consolidated

国United States of America

郵便番号80202-5117

電話番号13105362668

ウェブサイトhttps://www.davita.com/

企業コードDVA

上場日Oct 31, 1995

設立日1994

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

837.84K

-4.28%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

101.00K

+8.83%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

66.98K

+12.40%

Ms. Pamela M. Arway

Independent Chair of the Board

25.58K

+1.38%

Mr. David P. Maughan

Chief Operating Officer - Davita Kidney Care

20.58K

-84.60%

Mr. James O. Hearty

Chief Compliance Officer

16.63K

+38.27%

Mr. Christopher Michael (Chris) Berry

Chief Accounting Officer

15.96K

+31.62%

Ms. Phyllis R. Yale

Independent Director

13.20K

+2.71%

Ms. Barbara J. Desoer

Independent Director

12.66K

+2.83%

Dr. Gregory J. Moore, M.D., Ph.D.

Independent Director

6.45K

+5.70%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

837.84K

-4.28%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

101.00K

+8.83%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

66.98K

+12.40%

Ms. Pamela M. Arway

Independent Chair of the Board

25.58K

+1.38%

Mr. David P. Maughan

Chief Operating Officer - Davita Kidney Care

20.58K

-84.60%

Mr. James O. Hearty

Chief Compliance Officer

16.63K

+38.27%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

事業別USD

会社名

収益

比率

Patient service - Medicare and Medicare Advantage

6.37B

49.74%

Patient service - Commercial

4.03B

31.46%

Patient service - Other government

1.06B

8.28%

Patient service - Medicaid and Managed Medicaid

863.95M

6.74%

Other - Medicare and Medicare Advantage

463.73M

3.62%

Other

19.70M

0.15%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

Patient service - Medicare and Medicare Advantage

6.37B

49.74%

Patient service - Commercial

4.03B

31.46%

Patient service - Other government

1.06B

8.28%

Patient service - Medicaid and Managed Medicaid

863.95M

6.74%

Other - Medicare and Medicare Advantage

463.73M

3.62%

Other

19.70M

0.15%

株主

更新時刻: Sat, May 17

株主統計

種類

株主統計

比率

Berkshire Hathaway Inc.

44.76%

The Vanguard Group, Inc.

6.67%

BlackRock Institutional Trust Company, N.A.

3.86%

State Street Global Advisors (US)

2.91%

Weschler (R Ted)

2.89%

Other

38.91%

株主統計

比率

Berkshire Hathaway Inc.

44.76%

The Vanguard Group, Inc.

6.67%

BlackRock Institutional Trust Company, N.A.

3.86%

State Street Global Advisors (US)

2.91%

Weschler (R Ted)

2.89%

Other

38.91%

種類

株主統計

比率

Holding Company

44.77%

Investment Advisor

21.39%

Investment Advisor/Hedge Fund

19.83%

Individual Investor

4.74%

Hedge Fund

3.30%

Pension Fund

1.93%

Research Firm

1.60%

Bank and Trust

1.06%

Sovereign Wealth Fund

0.09%

Other

1.29%

機関投資家保有株

更新時刻: Mon, Jan 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

1259

77.68M

101.03%

-5.11M

2024Q4

1260

79.70M

99.28%

-3.76M

2024Q3

1214

80.97M

98.10%

-3.96M

2024Q2

1180

82.28M

96.62%

-4.32M

2024Q1

1166

84.15M

95.98%

-4.07M

2023Q4

1163

84.91M

95.56%

-3.04M

2023Q3

1159

85.40M

93.52%

-3.20M

2023Q2

1164

84.27M

92.30%

-4.64M

2023Q1

1168

84.01M

92.60%

-5.13M

2022Q4

1198

83.55M

92.31%

-8.33M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Berkshire Hathaway Inc.

35.14M

43.93%

-953.09K

-2.64%

Feb 19, 2025

The Vanguard Group, Inc.

5.19M

6.49%

-167.41K

-3.12%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

2.92M

3.65%

-212.41K

-6.79%

Dec 31, 2024

State Street Global Advisors (US)

2.34M

2.93%

-68.93K

-2.86%

Dec 31, 2024

Weschler (R Ted)

2.18M

2.73%

--

Aug 06, 2024

Invesco Capital Management LLC

1.24M

1.54%

+285.57K

+30.05%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.15M

1.44%

-14.40K

-1.24%

Dec 31, 2024

LSV Asset Management

1.03M

1.29%

-25.40K

-2.41%

Dec 31, 2024

Dimensional Fund Advisors, L.P.

902.42K

1.13%

-76.86K

-7.85%

Dec 31, 2024

Rodriguez (Javier J)

894.08K

1.12%

+18.82K

+2.15%

Mar 15, 2025

詳細を見る

140.490USD

DaVita Inc

140.490

概要

企業名